Development of three-dimensional biomaterials containing stem cells and neurotrophic factors for brain repair in Parkinson's disease
Therapeutical management of Parkinson's disease (PD) is predominantly focused on controlling motor symptoms and there is no gold standard treatment strategy. Consequently, the medical treatment is tailored to each patient, based on the severity of their symptoms and the adverse effects assoc...
Main Authors: | Torres-Ortega, P.V. (Pablo Vicente), Garbayo, E. (Elisa), Blanco-Prieto, M.J. (María José) |
---|---|
Format: | info:eu-repo/semantics/doctoralThesis |
Language: | eng |
Published: |
Universidad de Navarra
2022
|
Subjects: | |
Online Access: | https://hdl.handle.net/10171/63294 |
Similar Items
-
Effects of dexmedetomidine on subthalamic local field potentials in parkinson's disease
by: Martinez-Simon, A. (Antonio), et al.
Published: (2022) -
Glucocerebrosidase gene therapy in animal models of Parkinson Disease
by: Sucunza, D. (Diego), et al.
Published: (2021) - Enfermedad de parkinson y síndromes parkinsonianos
-
Abnormal alpha-synuclein interactions with Rab proteins in alpha-synuclein A30P transgenic mice
by: Dalfo, E. (Esther), et al.
Published: (2010) -
Developments in treatment for parkinson's disease
by: Cotzias, George C., ed.McDowell, Fletcher H., ed